DongKoo Bio&Pharma Co. Ltd (006620) — Financial Flexibility Index
DongKoo Bio&Pharma Co. Ltd (006620) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of ₩4.86 Billion (operating CF ₩1.20 Billion minus capex ₩3.66 Billion) represents 0% of total liabilities (₩158.34 Billion). Also explore net asset growth rate of DongKoo Bio&Pharma Co. Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
DongKoo Bio&Pharma Co. Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for DongKoo Bio&Pharma Co. Ltd across 10 annual periods. Check strategic asset allocation of DongKoo Bio&Pharma Co. Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for DongKoo Bio&Pharma Co. Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for DongKoo Bio&Pharma Co. Ltd. For the full company profile including market capitalisation, see 006620 company net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.31x | ₩42.81 Billion | ₩17.34 Billion | ₩138.73 Billion | ▲ +27.3% |
| 2023 | 0.24x | ₩19.55 Billion | ₩3.59 Billion | ₩80.66 Billion | ▼ -39.2% |
| 2022 | 0.40x | ₩27.89 Billion | ₩16.82 Billion | ₩69.95 Billion | ▼ -1.7% |
| 2021 | 0.41x | ₩22.17 Billion | ₩17.90 Billion | ₩54.66 Billion | ▲ +58.0% |
| 2020 | 0.26x | ₩12.76 Billion | ₩7.49 Billion | ₩49.70 Billion | ▼ -36.1% |
| 2019 | 0.40x | ₩18.91 Billion | ₩10.14 Billion | ₩47.07 Billion | ▲ +140.9% |
| 2018 | 0.17x | ₩5.37 Billion | ₩-791.20 Million | ₩32.18 Billion | ▼ -38.8% |
| 2017 | 0.27x | ₩10.32 Billion | ₩9.51 Billion | ₩37.85 Billion | ▼ -38.4% |
| 2016 | 0.44x | ₩19.14 Billion | ₩12.59 Billion | ₩43.27 Billion | ▲ +178.5% |
| 2015 | 0.16x | ₩9.25 Billion | ₩6.93 Billion | ₩58.22 Billion | — |